The RIQAS Therapeutic Drug EQA programme is designed to monitor the performance of an impressive 18 therapeutic drugs. Weighed in values are reported for each parameter.
- Accredited to ISO/IEC 17043
- Lyophilised for enhanced stability
- 100% human serum
- Bi-weekly reporting
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
- Weighed in values reported for each parameter
- Cycle Starts – March/September 2025
Cat No | Kit Size | Frequency | Parameters | |
---|---|---|---|---|
RQ9111 | 12 x 5ml | Bi-weekly (2 x 6 monthly cycles) | 18 | |
Parameters
- Amikacin
- Caffeine
- Carbamazepine
- Ciclosporin
- Digoxin
- Ethosuximide
- Gentamicin
- Lithium
- Methotrexate
- Paracetamol
- Phenobarbital
- Phenytoin
- Primidone
- Salicylic Acid
- Theophylline
- Tobramycin
- Valproic Acid
- Vancomycin
Please note, product availability may vary country to country.